Figure 1.
Therapy for hypoxemic critically ill adults: potential therapeutic targets derived
from translational work in fetal and high-altitude research. CO, carbon monoxide; H2S, hydrogen sulphide; HIF-1, hypoxia-inducible factor 1; PHD, prolyl hydroxylase.
Martin et al. Critical Care 2010 14:315 doi:10.1186/cc9078 |